Optimally targeting the centromedian nucleus of the thalamus for generalized epilepsy: A meta-analysis

Adeel Ilyas,Kathryn M. Snyder,Sandipan Pati,Nitin Tandon

DOI: https://doi.org/10.1016/j.eplepsyres.2022.106954

IF: 2.991

2022-08-01

Epilepsy Research

Abstract:BackgroundDeep brain stimulation (DBS) of the centromedian nucleus (CM) is an effective therapeutic option for select patients with generalized epilepsy. However, several studies suggest that success varies with active contact location within the CM and the exact target remains undefined.ObjectiveTo quantify the association between active contact location and outcomes across all published series of CM DBS.MethodsA literature search using PRISMA criteria was performed to identify all studies that reported active contact locations PLUS outcomes following DBS of the CM for epilepsy. Patient, disease, treatment, and outcome data were extracted for statistical analysis. Active contact locations were analyzed on a common reference frame and weighted by percent seizure reduction at last follow-up.ResultsFrom 184 studies that were screened for review, 3 studies comprising 47 patients met criteria for inclusion and were analyzed. At time of surgery, mean duration of epilepsy was 18 years. Pooled rates of atonic, atypical absence, generalized tonic-clonic, myoclonic, and tonic epilepsies were 38%, 74%, 68%, 14%, and 60%, respectively. Indirect targeting was used in all these studies. After a mean follow-up duration of 2.3 years, 87% of patients were deemed to be responders with mean seizure reduction of 73% (95% CI: [64%−81%]). Optimal location of the active contact was found to be at the dorsal border of the CM.ConclusionsSuccess following DBS of the CM for epilepsy varies by active contact location, even within the CM. Our findings suggest that stimulation within the dorsal region of the CM improves outcomes. Additional studies are needed to further refine these findings.

clinical neurology